Share our hope for a cure for ALL types of neuroblastoma

More children under five die from neuroblastoma than from any other childhood cancer, and one in three who do survive, will continue to suffer side effects from their actual treatment. Research is desperately needed to find more effective treatments so 100% of children diagnosed with neuroblastoma survive to live long and healthy lives.

Here are a few ways your can help this September: 

Support our latest Appeal

Help us fund the development of a promising new drug combination for aggressive neuroblastoma. This project was strongly recommended by our Scientific Advisory Board, due to the quality of research and potential to make a difference to treatments.

Make a difference here


Show your support and#GoGold by wearing one of our exclusive Neuroblastoma Australia Hope Bracelets, frangipani gold lapel pins, or our selection of gold wristbands, pins and ribbons.

With each purchase you'll be contributing to research into better, kinder and safer treatments for the children's cancer neuroblastoma.

#GoGold here

Support our Run2Cure Superheroes

On Saturday 5 and Sunday 6 September, we hosted our first ever virtual fundraising event - Run2Cure Local. From all across Australia, runners, joggers, walkers completed 1, 3, 5 or 10km to help raise funds for research into treatments for neuroblastoma. 

Fundraising continues throughout September, please consider donating to our Run2Cure Superheroes and their families who have shared their stories. 

Meet our Superheroes


Whether it’s a one off amount or setting up a regular commitment, all donations above $2 to Neuroblastoma Australia are tax deductible. Please donate today to help us live in a world where ALL children diagnosed with neuroblastoma get to grow up.

Please select a donation amount (required)
Set up a regular donationDonate

Thank you for supporting Neuroblastoma Australia during Childhood Cancer Awareness Month!

Venetoclax Combinations Venetoclax is a promising drug currently in trial for a number of cancers, including neuroblastoma BUT in combination with another agent we think it'll perform even better. Dr Jamie Fletcher from the Children's Cancer Institute needs funding to identify these combinations. Thank you for making this happen! Find out more

Booking for this event has now closed.